Progress in filovirus vaccine development: evaluating the potential for clinical use
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Progress in filovirus vaccine development: evaluating the potential for clinical use
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 10, Issue 1, Pages 63-77
Publisher
Informa UK Limited
Online
2010-12-16
DOI
10.1586/erv.10.152
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protection of Nonhuman Primates against Two Species of Ebola Virus Infection with a Single Complex Adenovirus Vector
- (2010) W. D. Pratt et al. Clinical and Vaccine Immunology
- Potent Vesicular Stomatitis Virus-Based Avian Influenza Vaccines Provide Long-Term Sterilizing Immunity against Heterologous Challenge
- (2010) J. A. Schwartz et al. JOURNAL OF VIROLOGY
- A Vesicular Stomatitis Virus-Based Hepatitis B Virus Vaccine Vector Provides Protection against Challenge in a Single Dose
- (2010) M. A. Cobleigh et al. JOURNAL OF VIROLOGY
- Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines against Angola Marburg Virus in Nonhuman Primates
- (2010) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Safety and Immunogenicity of Therapeutic DNA Vaccination in Individuals Treated with Antiretroviral Therapy during Acute/Early HIV-1 Infection
- (2010) Eric S. Rosenberg et al. PLoS One
- Prospects for immunisation against Marburg and Ebola viruses
- (2010) Thomas W. Geisbert et al. REVIEWS IN MEDICAL VIROLOGY
- Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic
- (2010) Alexander A. Bukreyev et al. VIROLOGY
- Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species
- (2010) Lisa E. Hensley et al. PLoS Pathogens
- Potential Factors Induced by Filoviruses that Lead to Immune Supression
- (2009) Mansour Mohamadzadeh CURRENT MOLECULAR MEDICINE
- Disease modeling for Ebola and Marburg viruses
- (2009) D. Bente et al. Disease Models & Mechanisms
- Therapeutic HPV DNA vaccines
- (2009) Archana Monie et al. Expert Review of Vaccines
- Replication-Deficient Ebolavirus as a Vaccine Candidate
- (2009) P. Halfmann et al. JOURNAL OF VIROLOGY
- Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus
- (2009) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Ebola outbreak has experts rooting for answers
- (2009) David Cyranoski NATURE
- Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule
- (2009) Nancy J. Sullivan et al. NATURE REVIEWS MICROBIOLOGY
- Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus-Based Vaccine
- (2009) Jason S. Richardson et al. PLoS One
- Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses
- (2009) Xiangguo Qiu et al. PLoS One
- EMERGING INFECTIOUS DISEASES: Scientists Puzzle Over Ebola-Reston Virus in Pigs
- (2009) D. Normile SCIENCE
- Discovery of Swine as a Host for the Reston ebolavirus
- (2009) R. W. Barrette et al. SCIENCE
- Human Ebola Outbreak Resulting from Direct Exposure to Fruit Bats in Luebo, Democratic Republic of Congo, 2007
- (2009) Eric M. Leroy et al. VECTOR-BORNE AND ZOONOTIC DISEASES
- Single-Dose, Therapeutic Vaccination of Mice with Vesicular Stomatitis Virus Expressing Human Papillomavirus Type 16 E7 Protein
- (2008) J. B. Liao et al. Clinical and Vaccine Immunology
- Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections
- (2008) D. L. Swenson et al. Clinical and Vaccine Immunology
- Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses
- (2008) Dana L Swenson et al. Expert Review of Vaccines
- Current progress of DNA vaccine studies in humans
- (2008) Shan Lu et al. Expert Review of Vaccines
- Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman Primates
- (2008) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice
- (2008) Maria A. Croyle et al. PLoS One
- Generation of biologically contained Ebola viruses
- (2008) P. Halfmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The global impact of vaccination against hepatitis B: A historical overview
- (2008) Alessandro R. Zanetti et al. VACCINE
- Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses
- (2008) Thomas W. Geisbert et al. VACCINE
- A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals
- (2008) Lijuan Yang et al. VIROLOGY
- SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector
- (2008) Sagar U. Kapadia et al. VIROLOGY
- Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge
- (2008) Alexander Bukreyev et al. VIROLOGY
- Protection against lethal challenge by Ebola virus-like particles produced in insect cells
- (2008) Yuliang Sun et al. VIROLOGY
- Newly Discovered Ebola Virus Associated with Hemorrhagic Fever Outbreak in Uganda
- (2008) Jonathan S. Towner et al. PLoS Pathogens
- Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
- (2008) Thomas W. Geisbert et al. PLoS Pathogens
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started